SA PRO
Free Account
IRadimed CorporationIRMDNASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating
Buy
2 analysts·Low coverage
100%
Rating Distribution
Strong Buy
00%
Buy
2100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Price is near analyst consensus — limited near-term upside expected.

Bear Case
$98.00
+0%
Consensus
$99.00
+1%
Bull Case
$100.00
+2%
Price Range2 analysts
Low
Consensus
High
$98.00
$100.00
Current Target
Current Price
$97.56
Upside to Target
$1.44

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Nov 3, 2025Roth Capital
iRadimed price target raised to $98 from $90 at Roth Capital
Target:$98.00
+16.5%from $84.11
Nov 3, 2025Lake Street
iRadimed price target raised to $100 from $75 at Lake Street
Target:$100.00
+18.9%from $84.11
Oct 31, 2025Roth Capital
iRadimed resumed with a Buy at Roth Capital
Target:$90.00
+17.8%from $76.42
Aug 2, 2024Roth Capital
iRadimed price target lowered to $60 from $65 at Roth MKM
Target:$60.00
+30.0%from $46.15
Jun 17, 2024Loop Capital Markets
Lake Street Capital Markets Reiterates Buy Rating on IRadimed Corp (IRMD)
Target:$60.00
+38.6%from $43.28

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance